TACR1 and infection: Future studies will need to perform more mechanistic studies, especially using SP/NK1R knockout or knockdown models of infection, and evaluate FDA-approved NK1R inhibitors if these future studies suggest a mechanistic role for SP/NK1R in WNV infection.